Omalizumab: an underutilized treatment option in bullous pemphigoid patients with co-morbidities

被引：15
|
作者：
De, D. [1 ]
Kaushik, A. [1 ]
Handa, S. [1 ]
Mahajan, R. [1 ]
Schmidt, E. [2 ,3 ]
机构：
[1] Postgrad Inst Med Educ & Res, Dept Dermatol Venereol & Leprol, Chandigarh, India
[2] Univ Lubeck, Dept Dermatol, Lubeck, Germany
[3] Univ Lubeck, Lubeck Inst Expt Dermatol LIED, Lubeck, Germany
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2021年 / 35卷 / 07期
关键词：
IGE;
D O I：
10.1111/jdv.17229
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E469 / E472
页数：4
相关论文
共 50 条
  • [41] Clinical effect of omalizumab as an adjuvant treatment to rituximab in patient with refractory bullous pemphigoid
    Kwon, Il Joo
    Kim, Taehee
    Yoo, Dae San
    Min, Seoyeon
    Kim, Soo-Chan
    Kim, Jong Hoon
    [J]. JOURNAL OF DERMATOLOGY, 2023, 50 (05): : 705 - 709
  • [42] Prevalence and Impact of Co-morbidities on Treatment of Breast Cancer
    Tao, M.
    Khalid, N.
    White, J. R.
    Owen, J. B.
    Pierce, L. J.
    Wilson, J. F.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S557 - S557
  • [43] IMPACT OF CO-MORBIDITIES ON DISEASE SEVERITY AND TREATMENT STRATEGY IN PATIENTS WITH INFLAMMATORY ARTHRITIS
    Symmons, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 47 - 48
  • [44] The treatment of long-term co-morbidities in older patients with metastatic cancer
    Cashman, J.
    Wright, J.
    Ring, A.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 72 : S49 - S49
  • [45] Methylphenidate Treatment in Germany - Are Co-Morbidities Taken into Account?
    Lindemann, Christina
    Angela, Kraut
    Ingo, Langner
    Rafael, Mikolajczyk
    Edeltraut, Garbe
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S226 - S226
  • [46] Does successful treatment of overactive bladder improve co-morbidities in patients with nocturia?
    Chin, Kai Sin
    Rose, Georgie E.
    Ervin, Claire F.
    Ong, Tee Juan
    Whishaw, David M.
    Bower, Wendy F.
    [J]. AUSTRALASIAN JOURNAL ON AGEING, 2019, 38 (04) : 242 - 248
  • [47] Interstitial cystitisCost, treatment and co-morbidities in an employed population
    Eric Q. Wu
    Howard Birnbaum
    Milena Mareva
    Andrew Parece
    Zihong Huang
    David Mallett
    Haya Taitel
    [J]. PharmacoEconomics, 2006, 24 (1) : 55 - 65
  • [48] The Effect Of Co-Morbidities On Productivity Loss In Patients With Asthma
    Ehteshami-Afshar, S.
    FitzGerald, J. M.
    Carlsten, C.
    Rousseau, R.
    Tan, W. C.
    Rolf, J.
    Sadatsafavi, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [49] Psychotherapeutic Groups for Elderly Patients with Multiple Co-Morbidities
    Schwartz, K.
    [J]. JOURNAL OF PSYCHOSOMATIC RESEARCH, 2016, 85 : 80 - 80
  • [50] Occurrence of Co-Morbidities in Patients with Soft Tissue Sarcoma
    van Herk-Sukel, Myrthe P. P.
    Shantakumar, Sumitra
    Overbeek, Lucy I. H.
    van Boven, Hester
    Penning-van Beest, Fernie J. A.
    Herings, Ron M. C.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S281 - S282
12345